No other ailment in the realm of rheumatic and musculoskeletal illnesses has changed as substantially as gout since the mid-1950s. During this time, the aetiology of gout has been determined, the tight connection with other diseases has been elucidated, a quick, unambiguous diagnostic test has been developed, and medicines effective in dissolving monosodium urate crystals and regulating inflammation have been widely accessible. All of these discoveries have led to the conclusion that gout is treatable, a conclusion that was previously thought to be beyond of reach. Unfortunately, in clinical practise, diagnosis and therapy of gout have not kept pace with scientific developments and are still falling short of established quality criteria. 

This contradiction is the focus of the current review paper, which aims to pique doctors’ interest in gout.